Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Ali Alhashim; Kawther Hadhiah; Zahra Al khalifah; Fatimah Mohammed Alhaddad; Sara A. Al ARhain; Faisal H. Bin Saif; Ahmad Abid; Omar Al Gamdi; Feras Alsulaiman; Mustafa AlQarni

doi:10.12659/AJCR.934744

09 February 2022 : Case report Saudi Arabia

Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Unusual clinical course, Adverse events of drug therapy, Educational Purpose (only if useful for a systematic review or synthesis)

Ali Alhashim

^1ABDEF*, Kawther Hadhiah^1EF, Zahra Al khalifah^1F, Fatimah Mohammed Alhaddad^1EF, Sara A. Al ARhain^1F, Faisal H. Bin Saif^1B, Ahmad Abid^1B, Omar Al Gamdi^1F, Feras Alsulaiman

^1BE, Mustafa AlQarni^1EF

DOI: 10.12659/AJCR.934744

Am J Case Rep 2022; 23:e934744

Authors information Article notes Copyright and License information

Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman

Export

Export Article Citation

Export file: The selected type of file is required

Content:

Share via email

Share method:

Content:

Preview:

Your Privacy